Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects?
about
Medical management of brain tumors and the sequelae of treatment.Prospects of immune checkpoint modulators in the treatment of glioblastomaGliomas and the vascular fragility of the blood brain barrierDexamethasone alleviates tumor-associated brain damage and angiogenesisACR Appropriateness Criteria® pre-irradiation evaluation and management of brain metastases.Use of dexamethasone in patients with high-grade glioma: a clinical practice guidelineThe impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients.The potential role of exercise in neuro-oncologyThe impact of dietary isoflavonoids on malignant brain tumorsMyxosarcoma in the eye and brain in a dog.The relationship between corticosteroids and symptoms in patients with primary brain tumors: utility of the Dexamethasone Symptom Questionnaire-ChronicCollaboration in the presence of cerebral edema: The complications of steroids.Effects of Dexamethasone and Placebo on Symptom Clusters in Advanced Cancer Patients: A Preliminary Report.Controlled rehabilitative and supportive care intervention trials in patients with high-grade gliomas and their caregivers: a systematic reviewDexamethasone retrodialysis attenuates microglial response to implanted probes in vivo.Role of corticosteroids in palliative care.Stereotactic radiosurgery boost to the resection cavity for cerebral metastases: Report of overall survival, complications, and corticosteroid protocol.The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline.Irinotecan and bevacizumab in recurrent glioblastoma multiforme.Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a reviewCorticosteroid-use in primary and secondary brain tumour patients: a review.Brain metastasis and treatment.Corticosteroid use in neuro-oncology: an update.Clinical Relevance of Steroid Use in Neuro-Oncology.Psychometric validation of the functional assessment of cancer therapy--brain (FACT-Br) for assessing quality of life in patients with brain metastases.Minimal important differences in the EORTC QLQ-C15-PAL to determine meaningful change in palliative advanced cancer patients.An in vitro model for dengue virus infection that exhibits human monocyte infection, multiple cytokine production and dexamethasone immunomodulation.Adjunctive role of MMP-9 inhibition along with conventional anti-tubercular drugs against experimental tuberculous meningitis.AT-RvD1 combined with DEX is highly effective in treating TNF-α-mediated disruption of the salivary gland epitheliumPsychometric validation of the Brain Symptom and Impact Questionnaire (BASIQ) version 1.0 to assess quality of life in patients with brain metastases.A longitudinal, qualitative and quantitative exploration of daily life and need for rehabilitation among patients with high-grade gliomas and their caregivers.Evolution of the Karnosky Performance Status throughout life in glioblastoma patients.Steroid-sparing effects of angiotensin-II inhibitors in glioblastoma patients.Impact of Angiotensin-II receptor blockers on vasogenic edema in glioblastoma patients.Treatment of Brain Metastases.
P2860
Q26992174-351E53C8-7DA6-4C0E-91AB-91243D5F307FQ28081371-253E8FA0-F6B9-4C63-BE9E-71F23084DC2DQ28081953-85A4D98A-7B48-4354-A2F0-69FA63119D5BQ28542092-C5C60F7E-EB2D-405C-883B-6E4941DDEC78Q30833655-62223BDC-1F69-4974-9307-F15966B49AADQ33763941-F71E0CA1-7EC1-47E8-B45F-A29AA9B4798EQ34293163-3FE1CA59-3EE0-463D-841D-91FC21D21EF1Q34473328-4EE418B8-25B2-452D-8720-54CBFB9645B1Q35000427-310D2F63-4520-48E4-A555-36E549B804DEQ35209733-D80B0893-A9AE-4DC8-B028-9C8A8E90664BQ35815301-5EDF5DFC-7238-4C82-A711-1FA9C6A6C3E3Q35999184-3E35CEAD-1613-480D-9661-BC39A5EF4458Q36673441-65B85DAD-921C-40A8-AB3F-768E5C1C370DQ36681807-63AF3B70-95BF-4BE9-BB1A-B0C366064AB5Q36899857-0C5843D9-AEF0-4AAE-8A41-68D09324B8B3Q37010936-DCD0BB34-3C68-4B64-9EB0-BB1A36EE319BQ37382256-28F3BAF6-B445-442D-846B-F419E28BFC99Q37643538-7FF13DAB-6C94-4531-BE5F-CE568E55F9AEQ37850802-27DD5707-EFBD-4E6A-8738-5EADC4BE8D15Q37862136-2521EBD5-1574-4CB6-86A4-0474F0B0ED9BQ37942476-E07B96A9-C0B3-4877-845B-184D5D22CFE7Q38314890-5D8E91C1-1EA6-430D-815F-DAEF5B46FA1CQ38512587-2197E304-1062-4556-843C-7791E47B8D34Q38990624-598B1AB6-A5CA-46A6-AD62-9147BD9956F9Q39305363-38E5A8CE-3F92-40D0-8D1F-40E748076179Q39440990-1B814773-CEEB-4D7E-97FE-562D232B3641Q40429067-8118597F-B9A4-498A-A743-2914BCDCA4CCQ40623056-8059ABD2-5C88-437C-9ED3-DA562BBF76A8Q41460908-2D2CEC00-00C5-4AE8-8CC7-8C2CE0466EB1Q41586115-E8972CA1-1EF5-47F8-8FE2-44F74194B74DQ41789592-395D34AE-D848-4241-B78A-5F4D51123C88Q48048661-7A161C86-750E-43B0-A632-DDBDB1597667Q48487650-09B47A64-DF90-43D8-AAC3-821F21F895A5Q49015944-456F717D-47F1-484B-98AF-695BBC7BD3A7Q53827061-B4ACD188-F82D-423B-92F9-E6DB092C13A2
P2860
Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects?
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Dexamethasone treatment in pat ...... its outweigh the side-effects?
@en
Dexamethasone treatment in pat ...... its outweigh the side-effects?
@nl
type
label
Dexamethasone treatment in pat ...... its outweigh the side-effects?
@en
Dexamethasone treatment in pat ...... its outweigh the side-effects?
@nl
prefLabel
Dexamethasone treatment in pat ...... its outweigh the side-effects?
@en
Dexamethasone treatment in pat ...... its outweigh the side-effects?
@nl
P2093
P1476
Dexamethasone treatment in pat ...... its outweigh the side-effects?
@en
P2093
Christina Hempen
Clemens F Hess
Elisabeth Weiss
P2888
P304
P356
10.1007/S00520-001-0333-0
P577
2002-02-09T00:00:00Z